News

The Phase II study was designed to test the effectiveness of Lymphoseek in identifying lymphatic tissue and to evaluate the drug safety of the compound. The pathology results

The non-small cell lung cancer (NSCLC) program consists of two trials. The first is a Phase I trial in which investigators will determine the safety, tolerability and a

Data from the pilot study demonstrated that Symphony has safely and reliably monitored blood glucose levels in the operating room and surgical intensive care unit at Tufts. There

Aricept, an acetylcholinesterase inhibitor developed by Eisai, is claimed to be the only approved prescription medicine for the treatment of Alzheimer’s disease in Japan. It is believed to

Under the terms of the agreement, Transition will receive a $7 million upfront payment, and may also receive up to $130 million in potential development and sales milestones,

According to the report released by IMS, the total US prescription sales reached $286.5 billion, with slower sales growth resulting from loss of exclusivity of branded medicines, fewer

The drug which was initially discovered at Imperial College was based on a gut hormone called oxyntomodulin that helped obese people lose weight by lowering their appetite and

This double-blind, placebo-controlled clinical trial is designed to assess the efficacy and safety of Vilazodone. It will also further evaluate genetic biomarkers of response to Vilazodone, which may

The results were taken from two sub-analyses of fistula patients from Abbott’s 854-patient, one-year Phase III Charm trial for Humira. Patients were followed through a second year of